Furthermore, increased levels of survivin are associated with a poor prognosis in numerous tumors [14]–[18], although some reports indicate that an elevated expression of survivin splice variants may represent a favorable prognostic marker in some cancers [19]. This evidence concerns the gene BIRC5 and cancer.